** Shares of MGC Pharmaceuticals MXC.AX jump as much as
5.3% to A$0.060, snapping its three-day losing streak
** European-based biopharma co says its Canadian-based
development and distribution partner Glow LifeTech GLOW.CD
submitted an application to Health Canada, a government
department responsible for national health policy urn:newsml:reuters.com:*:nASX7yKcq9
** Says application is to obtain product licenses for
Artemic as a Natural Health Product urn:newsml:reuters.com:*:nGLF6BmL9c
** Artemic is a clinically tested oral spray which
statistically improved recovery of COVID-19 patients
** "The global demand for natural health products has been
driven to new highs during pandemic and Health Canada approved
products are globally recognized as safe and high-quality," said
Rob Carducci, Chief Commercial Officer, Glow LifeTech
** Stock has risen over two-fold this year, as of last close
(Reporting by Vasudha Kaukuntla in Bengaluru)
((Vasudha.Kaukuntla@thomsonreuters.com))